Atlas Trials

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

Clinical trial NCT02849886 · TERMINATED

Trial details

NCT number
NCT02849886
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseHematological Malignancies
Start date
2019-04-10
Primary completion
2021-12-26
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.